Physician profile
Roger E Gregush
NPI 1164942413
$8,423.19
in general payments reported to CMS, 2019-2025
11 companies · $743 in 2025
The $743 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.61 · 2020: $29.78 · 2021: $1,280 · 2022: $178 · 2023: $2,498 · 2024: $3,663 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,161 · Food and Beverage: $2,743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,161.20 |
| Food and Beverage | $2,742.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,200.99 | 2021-2025 | Mako, Aequalis, Triathlon |
| Smith+Nephew, INC. | $1,987.51 | 2023-2024 | Journey II, Redapt, Legion Revision |
| Mid-Atlantic Surgical Systems, LLC | $1,209.83 | 2021 | |
| Medical Device Business Services, INC. | $442.76 | 2024 | Tfn-Advance |
| Depuy Synthes Sales INC. | $401.18 | 2022-2025 | Na, Velys |
| Orthalign INC | $83.57 | 2025 | Orthalign Plus |
| Medtronic USA, INC. | $31.61 | 2019 | |
| Zimmer Biomet Holdings, INC. | $19.26 | 2021 | |
| Endo Pharmaceuticals INC. | $16.96 | 2020 | |
| Novo Nordisk INC | $16.70 | 2022 | |
| Bioventus LLC | $12.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Gregush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.